GGrantIndex
← Search

SYNTHETIC IMMUNE RECEPTOR TARGETING PSCA FOR THE TREATMENT OF PROSTATE CANCER

$1,237,500FY2022Defense Health AgencyDOD

University Of Southern California, Los Angeles CA

Investigators

View source on USAspending →
SYNTHETIC IMMUNE RECEPTOR TARGETING PSCA FOR THE TREATMENT OF PROSTATE CANCER · GrantIndex